人体本源血凝固因子XIII复合物的冷EM结构
Sneha Singh1, Gregor Hagelueken2, Deniz Ugurlar3
1Arijit Biswas Laboratory, Institute for Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.
Blood
|October 24, 2024
概括
研究人员揭示了人类凝血因子XIII (FXIII) -A2B2复合体的第一个冷电子显微镜结构. 这种结构澄清了FXIII亚单元相互作用和FXIII缺乏的分子基础,有助于理解出血障碍.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 血液学 血液学 血液学
背景情况:
- 人体凝血因子XIII (FXIII) 对于稳定血栓至关重要.
- 之前的结构研究只关注FXIII-A2同极体,使完整的FXIII-A2B2复合结构难以捉摸.
- 了解FXIII结构对于解释FXIII缺陷至关重要.
研究的目的:
- 为了确定原生人体血衍生的FXIII-A2B2复合物的高分辨率结构.
- 为了阐明FXIII复合体内的子单元相互作用.
- 为了提供对FXIII缺乏的分子基础的结构性见解.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定FXIII-A2B2复合物的结构.
- 分析高分辨率结构以了解子单元接口.
- 从患有FXIII缺乏症的患者中检测F13A1基因中的新突变.
主要成果:
- 人类FXIII-A2B2复合体的冷EM结构在2.4 Å分辨率下得到解析.
- 观察到一种独特的"冠状"组件,其中FXIII-B子单元与FXIII-A2二次数交叉.
- 他们揭示了FXIII-A和FXIII-B子单元之间的详细相互作用,包括特定的Sushi域相互作用.
- 该结构阐明了新型FXIII缺陷突变的病因基础,解释了主要的负面影响.
结论:
- 确定的FXIII-A2B2结构为复合体提供了前所未有的原子细节.
- 这些结构信息解释了FXIII缺乏症背后的分子机制.
- 这些发现将结构生物化学与FXIII缺乏的临床表现联系起来.
更多相关视频
09:25Do's and Don'ts of Cryo-electron Microscopy: A Primer on Sample Preparation and High Quality Data Collection for Macromolecular 3D Reconstruction
Published on: January 9, 2015
46.1K
08:27Expression and Purification of the Human Lipid-sensitive Cation Channel TRPC3 for Structural Determination by Single-particle Cryo-electron Microscopy
Published on: January 7, 2019
9.4K
相关概念视频
Cryo-electron Microscopy
3.2K
Conventional electron microscopy (EM) involves dehydration, fixation, and staining of biological samples, which distorts the native state of biological molecules and results in several artifacts. Also, the high-energy electron beam damages the sample and makes it difficult to obtain high-resolution images. These issues can be addressed using cryo-EM, which uses frozen samples and gentler electron beams. The technique was developed by Jacques Dubochet, Joachim Frank, and Richard Henderson, for...
3.2K
Extrinsic and Intrinsic Pathways of Hemostasis
5.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.9K
Coagulation
5.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.1K
